FRCA Notes


Status epilepticus

The CRQ question on seizures from September 2022 (pass rate 64%) correlated most with overall performance on the exam. Despite the high pass rate, marks were lost on the definition of status epilepticus, and toxic effects of phenytoin.

The marks from the 2017 SAQ were a fairly even split between initial management, further management and complications.

A CRQ on epilepsy from 2024 focussed more on hyponatraemia and its management.

Resources


  • Status epilepticus is a medical emergency defined by:
    • >30mins of continuous seizure activity, or
    • Sequential seizures without full recovery of consciousness between seizures
  • Status epilepticus can be classified as:
    • Convulsive status epilepticus (which can be further classified according to seizure type e.g. generalised, partial)
    • Non-convulsive status epilepticus
  • The distinction is partially academic as it does not influence management strategies

Non-convulsive status epilepticus

  • There are EEG findings of uncontrolled seizures without clinically apparent convulsions, e.g. due to:
    • Uncontrolled absence or complex partial seizures
    • Patient concurrently anaesthetised
  • Accounts for up to 25% of status epilepticus

  • Initially there are compensatory mechanisms which aim to prevent cerebral damage during the first 30 - 60mins, such as:
    • Raised CMRO2
    • Raised CBF
    • Raised glucose and lactate concentrations
    • Associated sympathetic cardiovascular changes i.e. raised CO, MAP, HR and CVP

  • Beyond the initial period, if seizures aren't terminated, the compensatory mechanisms begin to fail
  • Cerebral auto-regulation is impaired, leading to cerebral hypoxia, hypoglycaemia, cerebral oedema and raised ICP
  • This causes:
    • Electrolyte imbalance with hyponatraemia and hyperkalaemia
    • Metabolic acidosis
    • Eventually DIC, rhabdomyolysis and multi-organ failure

  • These changes occur in both convulsive and non-convulsive status epilepticus, though happen more rapidly in the former

  • In short, any cause of seizures
  • Some patients may develop new-onset refractory status epilepticus ( NORSE ) without a history of prior seizures
    • This is associated with high mortality (∽20%) and is often due to unknown causes (50%) or autoimmune disease (36%)

Category Examples
Cardiovascular Stroke
Eclampsia
Ischaemic or hypertensive encephalopathy
Infectious Meningo-encephalitis
Intra-cerebral abscesses
Febrile convulision (6m - 5yrs)
Intra-cranial/trauma Intra-cerebral bleed
TBI
Neurosurgical intervention
Blocked VP shunt
Autoimmune Cerebral vasculitis
Autoimmune encephalitis
Metabolic Hypo- K+, Na+, Mg2+, Ca2+
Hypoglycaemia
Uraemia
Hyperammonaemia
Drug overdose or withdrawal
Inborn error of metabolism
Iatrogenic Sympathomimetics
TCAs
Olanzapine
High-dose TXA
Beta-lactams
Prochlorperazine
Neoplastic SOL
Congenital Poorly controlled epilepsy
Cerebral palsy


  • Prompt treatment is vital, as neuronal GABA receptors undergo altered localisation during seizures making treatment harder and harder the longer the seizure goes on
  • Naturally one will perform management and investigatory steps somewhat simultaneously, but the latter is ensconced in a separate section below for clarity
  • If seizure not self-terminating within a few minutes

  • ABCDE approach
  • Treat obvious causative factors:
    • Hypoglycaemia - IV dextrose
    • Hypoglycaemia associated with alcoholism - IV thiamine (Pabrinex) then IV dextrose
    • Hyponatraemia - IV hypertonic saline e.g. 3ml/kg 2.7% NaCl if Na+ <130mmol/L
    • Eclampsia - IV magnesium

  • Use the patient's own management plan if they have one
  • If not, administer the benzodiazepine du jour:
    • Lorazepam 4mg (0.1mg/kg) IV
    • Midazolam 10mg buccally
    • Diazepam 10 - 20mg (0.2 - 0.3mg/kg) rectally

If seizure not terminated after five minutes

  • Give a second dose of benzodiazepine
  • Start readying second line agents

If seizure still not terminated after a further five minutes

  • Give a second line agent:
    • Levetiracetam 40 - 60mg/kg (up to 3g)
    • Phenytoin 20mg/kg (up to 2g)
    • Sodium valproate 10 - 30mg/kg (according to NICE; unlike the other two the BNF doesn't list status epilepticus as an indication)
  • Administer regular doses of chosen anticonvulsant(s) thereafter e.g. 1g keppra BD, phenytoin 100mg TDS
  • Call the friendly neighbourhood anaesthetists or intensivist

If seizure still not terminated i.e. refractory status epilepticus

  • Induce general anaesthesia e.g. propofol or thiopentone
  • Although NMBA should be used for intubation, they shouldn't be continued thereafter

If seizure still not terminated i.e. "super-refractory status epilepticus"

  • Further anaesthetic agent infusion(s) titrated to burst-suppression:
    • Propofol
    • Midazolam
    • Thiopentone
    • Ketamine (0.4mg/kg/hr then up-titrated)
  • Continue infusing said drugs for 12hrs post-cessation of seizure activity

  • Other putative pharmacological agents:
    • Volatile anaesthetics
    • Magnesium
    • Lidocaine
    • Pyridoxine

  • Non-pharmacological therapies a.k.a. kitchen sink:
    • Hypothermia; may reduce status duration but with increased adverse events and no 90-day functional outcome difference
    • Ketogenic diet
    • Deep brain stimulation

  • A failure to investigate and treat the underlying cause will contribute to refractory seizures
  • Some of these tests can be performed alongside management above; some will have to wait until a modicum of clinical stability is established

Blood tests

  • VBG or ABG
  • FBC | Urea and creatinine | LFTs | Clotting inc. fibrinogen
  • Electrolytes including magnesium, calcium and ammonia
  • Glucose
  • Toxicology screen
  • Anti-epileptic drug levels
  • Blood cultures

Neurological investigations

  • Neuroimaging e.g. CT brain, MRI head
  • Lumbar puncture - may see pleocytosis as a consequence of status epilepticus
  • EEG
  • The opinion of a neurologist and/or neurophysiologist

Neurological

  • Excitotoxic CNS injury and hypoxia
  • Cerebral oedema
  • Cerebral venous thrombosis
  • Intracerebral haemorrhage

Non-neurological

System Complications
Respiratory Hypoxia
Aspiration
Pulmonary oedema
Hypercapnoea
Apnoea
Cardiovascular Hypertension
Dysrhythmia
Myocardial infarction
Cardiogenic shock
Cardiac arrest
Renal AKI (ATN)
Rhabdomyolysis
Gastrointestinal Acute liver injury
Acute pancreatitis
Haematological DIC
MSK Fractures
Raised CK
Metabolic Hyperthermia
Hypoglycaemia
Hyponatraemia
Hyperkalaemia
Metabolic or respiratory acidosis

  • <33% of patients with refractory convulsive status epilepticus will return to pre-morbid functional level
Category In-hospital mortality 30-day mortality
Convulsive status ≤21% ≤27%
Non-convulsive status ≤50% (up to 75% if delayed diagnosis) ≤65%
Refractory status ≤61% ≤39%